Published in J Clin Invest on November 01, 1997
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest (2001) 5.49
The many substrates of presenilin/γ-secretase. J Alzheimers Dis (2011) 2.02
Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol (2004) 1.64
Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease. Biol Psychiatry (2014) 1.54
Amyloid accomplices and enforcers. Protein Sci (2004) 1.36
A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging. Biochem J (2005) 1.35
Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. Am J Pathol (2005) 1.33
Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum. Brain (2015) 1.31
The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo. J Neurosci (2009) 1.31
Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease. Nat Rev Drug Discov (2013) 1.29
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease. Mol Neurodegener (2014) 1.24
The p75 neurotrophin receptor can induce autophagy and death of cerebellar Purkinje neurons. J Neurosci (2004) 1.21
Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). Int J Exp Pathol (2005) 1.17
Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice. J Neurosci (2006) 1.16
The dendritic hypothesis for Alzheimer's disease pathophysiology. Brain Res Bull (2013) 1.14
Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons. J Neurosci (2012) 1.11
Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease. EMBO J (2011) 1.10
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. J Cell Mol Med (2009) 1.09
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res (2007) 1.06
Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med (2002) 1.06
Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo. Mol Brain (2013) 1.01
Mechanisms of islet amyloidosis toxicity in type 2 diabetes. FEBS Lett (2013) 1.00
Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interaction. Ann Neurol (2009) 0.97
Pro-NGF from Alzheimer's disease and normal human brain displays distinctive abilities to induce processing and nuclear translocation of intracellular domain of p75NTR and apoptosis. Am J Pathol (2006) 0.97
Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol (2004) 0.95
Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease. PLoS One (2011) 0.94
p75 neurotrophin receptor mediates apoptosis in transit-amplifying cells and its overexpression restores cell death in psoriatic keratinocytes. Cell Death Differ (2010) 0.94
Ceramide signaling in cancer and stem cells. Future Lipidol (2008) 0.92
RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease. Front Biosci (Schol Ed) (2012) 0.89
A DR6/p75(NTR) complex is responsible for β-amyloid-induced cortical neuron death. Cell Death Dis (2013) 0.89
p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease. Mol Psychiatry (2015) 0.88
Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Neurobiol Dis (2010) 0.88
Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease. Neurobiol Aging (2013) 0.86
The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders. Exp Neurobiol (2011) 0.86
Amyloid-beta binds catalase with high affinity and inhibits hydrogen peroxide breakdown. Biochem J (1999) 0.84
p75 reduces beta-amyloid-induced sympathetic innervation deficits in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A (2009) 0.83
In vitro dedifferentiation of melanocytes from adult epidermis. PLoS One (2011) 0.82
Neurotrophin receptor p75 mediates the uptake of the amyloid beta (Aβ) peptide, guiding it to lysosomes for degradation in basal forebrain cholinergic neurons. Brain Struct Funct (2013) 0.82
Resistance to the apoptotic effect of aggregated amyloid-beta peptide in several different cell types including neuronal- and hepatoma-derived cell lines. Biochem J (1998) 0.82
The p75NTR extracellular domain: a potential molecule regulating the solubility and removal of amyloid-β. Prion (2011) 0.81
Dynamic nature of the p75 neurotrophin receptor in response to injury and disease. J Neuroimmune Pharmacol (2014) 0.81
The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration. BMC Neurosci (2006) 0.80
Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students. J Neurochem (2016) 0.80
p75NTR is mainly responsible for Aβ toxicity but not for its internalization: a primary study. Neurol Sci (2011) 0.80
Inhibition of RhoA GTPase and the subsequent activation of PTP1B protects cultured hippocampal neurons against amyloid β toxicity. Mol Neurodegener (2011) 0.80
TRAF6 and p62 inhibit amyloid β-induced neuronal death through p75 neurotrophin receptor. Neurochem Int (2012) 0.79
Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders. J Neural Transm (Vienna) (2015) 0.78
Increased expression of the homologue of enhancer-of-split 1 protects neurons from beta amyloid neurotoxicity and hints at an alternative role for transforming growth factor beta1 as a neuroprotector. Alzheimers Res Ther (2012) 0.78
Alzheimer's disease and brain development: common molecular pathways. Front Biosci (1998) 0.78
Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission. Neuroscientist (2015) 0.78
Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo. Am J Pathol (1999) 0.78
Genetic polymorphisms of nerve growth factor receptor (NGFR) and the risk of Alzheimer's disease. J Negat Results Biomed (2012) 0.78
p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation. Cell Mol Neurobiol (2008) 0.77
A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression. PLoS One (2014) 0.76
p75 Neurotrophin Receptor in the Skin: Beyond Its Neurotrophic Function. Front Med (Lausanne) (2017) 0.75
Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease. Int J Mol Sci (2016) 0.75
Computational Studies of Beta Amyloid (Aβ42) with p75NTR Receptor: A Novel Therapeutic Target in Alzheimer's Disease. Adv Bioinformatics (2014) 0.75
Cholinergic neurons-keeping check on amyloid β in the cerebral cortex. Front Cell Neurosci (2013) 0.75
Association of TrkA and APP Is Promoted by NGF and Reduced by Cell Death-Promoting Agents. Front Mol Neurosci (2017) 0.75
Differential levels of p75NTR ectodomain in CSF and blood in patients with Alzheimer's disease: a novel diagnostic marker. Transl Psychiatry (2015) 0.75
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07
The Fas death factor. Science (1995) 13.81
The molecular pathology of Alzheimer's disease. Neuron (1991) 8.21
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem (1995) 5.34
Hydrogen peroxide mediates amyloid beta protein toxicity. Cell (1994) 5.19
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci (1993) 4.60
Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature (1996) 3.92
A familial Alzheimer's disease locus on chromosome 1. Science (1995) 3.14
Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron (1996) 3.14
Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell (1994) 2.88
Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci (1994) 2.81
The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem Sci (1995) 2.70
Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem (1996) 2.68
Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol (1993) 2.67
p75 and Trk: a two-receptor system. Trends Neurosci (1995) 2.39
Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature (1996) 2.28
Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature (1996) 2.14
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.82
Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport (1994) 1.81
Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science (1989) 1.69
Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J Cell Biol (1995) 1.51
Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc Natl Acad Sci U S A (1993) 1.51
High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J Biol Chem (1994) 1.48
A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol (1995) 1.43
Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci U S A (1990) 1.18
Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci (1990) 1.17
Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav Brain Res (1993) 1.17
NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron (1991) 1.13
Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm Park Dis Dement Sect (1992) 1.11
Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res (1994) 1.08
Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J Neurosci (1990) 1.07
Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc Natl Acad Sci U S A (1994) 1.06
Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor. J Neurosci (1996) 1.04
HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J Neurosci (1993) 1.04
Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci U S A (1988) 0.98
Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon. Neuroscience (1989) 0.98
Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J Neurosci (1992) 0.97
Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Exp Neurol (1992) 0.94
Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels. Exp Cell Res (1996) 0.94
Isolation of a proteolytically derived domain of the insulin receptor containing the major site of cross-linking/binding. Biochemistry (1989) 0.94
The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest (1994) 0.94
Zone mapping of the binding domain of the rat low affinity nerve growth factor receptor by the introduction of novel N-glycosylation sites. J Biol Chem (1995) 0.94
Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J Biol Chem (1995) 0.91
Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain. Brain Res (1987) 0.89
Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain Res (1993) 0.88
The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta peptide but not aggregated, cytotoxic amyloid-beta peptide. J Biol Chem (1996) 0.88
Culture of dorsal root ganglion neurons from aged rats: effects of acetyl-L-carnitine and NGF. Int J Dev Neurosci (1992) 0.86
NGF augmentation rescues trigeminal ganglion and principalis neurons, but not brainstem or cortical whisker patterns, after infraorbital nerve injury at birth. J Comp Neurol (1993) 0.86
Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction. Brain Res (1995) 0.85
Gene expression in cells of the central nervous system. Prog Neurobiol (1992) 0.83
Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp Neurol (1993) 0.81
In vivo NGF treatment increases proliferation in the primary sympathetic ganglia of chick embryos. Dev Biol (1997) 0.81
Missing Alzheimer's gene found. Science (1995) 0.78
beta-APP cognitive function versus beta-amyloid--induced cell death. Ann N Y Acad Sci (1996) 0.77
[Pathogenetic factors of Alzheimer disease]. Z Gerontol Geriatr (1995) 0.77
Effects of nerve growth factor on the survival of primary cultured adult and aged mouse sensory neurons. J Neurosci Res (1993) 0.77
Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature (1988) 3.57
Coated vesicles transport newly synthesized membrane glycoproteins from endoplasmic reticulum to plasma membrane in two successive stages. Proc Natl Acad Sci U S A (1980) 3.51
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.06
Interaction of cross-linking agents with the insulin effector system of isolated fat cells. Covalent linkage of 125I-insulin to a plasma membrane receptor protein of 140,000 daltons. J Biol Chem (1979) 2.83
Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues. J Biol Chem (1989) 2.81
The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes. J Biol Chem (1980) 2.51
Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations. J Biol Chem (1989) 2.39
Treatment of children with port-wine stains using the flashlamp-pulsed tunable dye laser. N Engl J Med (1989) 2.30
Actin in growing nerve cells. Nat New Biol (1971) 2.27
Tropomyosin in brain and growing neurones. Nat New Biol (1973) 2.20
Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries. Proc Natl Acad Sci U S A (1980) 2.15
Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. Proc Natl Acad Sci U S A (1987) 2.10
Evidence that coated vesicles isolated from brain are calcium-sequestering organelles resembling sarcoplasmic reticulum. J Cell Biol (1977) 2.09
Transport of the membrane glycoprotein of vesicular stomatitis virus to the cell surface in two stages by clathrin-coated vesicles. J Cell Biol (1980) 2.08
Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med (1977) 2.06
Identification of a protein kinase as an intrinsic component of rat liver coated vesicles. Biochemistry (1984) 2.03
Insulin increases the association of Akt-2 with Glut4-containing vesicles. J Biol Chem (1998) 1.95
Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95
Photoageing: mechanism, prevention and therapy. Br J Dermatol (2007) 1.94
Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARgamma and C/EBPalpha. J Biol Chem (1999) 1.88
Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature (1989) 1.88
Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. J Immunol (1989) 1.82
Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I. Nature (1983) 1.81
Molecular defect of the band 3 protein in southeast Asian ovalocytosis. N Engl J Med (1990) 1.77
Purification of coated vesicles by agarose gel electrophoresis. J Cell Biol (1981) 1.77
Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest (1995) 1.75
A chemical comparison of tropomyosins from muscle and non-muscle tissues. J Mol Biol (1975) 1.72
Human melanogenesis is stimulated by diacylglycerol. J Invest Dermatol (1989) 1.71
Photoaging/photodamage and photoprotection. J Am Acad Dermatol (1990) 1.63
gp160, a tissue-specific marker for insulin-activated glucose transport. Proc Natl Acad Sci U S A (1994) 1.63
Muscle-like contractile proteins and tubulin in synaptosomes. Proc Natl Acad Sci U S A (1974) 1.60
E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci (1994) 1.59
Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis. Proc Natl Acad Sci U S A (1991) 1.59
Experiments on pollutant transport from soil into residential basements by pressure-driven airflow. Environ Sci Technol (1987) 1.58
SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J (2001) 1.54
Effect of aging and habitual sun exposure on the genetic response of cultured human keratinocytes to solar-simulated irradiation. J Invest Dermatol (1992) 1.52
Topically applied diacylglycerols increase pigmentation in guinea pig skin. J Invest Dermatol (1995) 1.52
Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res (1987) 1.51
Antimicrobial proteins of murine macrophages. Infect Immun (1993) 1.50
DNA damage enhances melanogenesis. Proc Natl Acad Sci U S A (1996) 1.48
Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake. Ann N Y Acad Sci (1999) 1.46
A unique proteolytic cleavage site on the beta subunit of the insulin receptor. J Biol Chem (1981) 1.46
Coordinate modulation of D-glucose transport activity and bilayer fluidity in plasma membranes derived from control and insulin-treated adipocytes. Proc Natl Acad Sci U S A (1980) 1.45
Unique cytochalasin B binding characteristics of the hepatic glucose carrier. Biochemistry (1983) 1.43
Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci (2009) 1.38
Decreased expression of glucose transporter in muscle from insulin-resistant patients. Am J Physiol (1991) 1.36
Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer (1976) 1.33
Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci U S A (1997) 1.33
The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J Biol Chem (1996) 1.31
Uncoupling of the spectrin-based skeleton from the lipid bilayer in sickled red cells. Science (1991) 1.30
Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J (2000) 1.30
Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res (1992) 1.30
Regulation of glucose-transporter function. Diabetes Care (1990) 1.29
p53 is essential for chemotherapy-induced hair loss. Cancer Res (2000) 1.29
Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol (1987) 1.28
KDEL proteins are found on the surface of NG108-15 cells. Brain Res Mol Brain Res (1999) 1.27
Coated vesicles from rat liver and calf brain contain cryptic mannose 6-phosphate receptors. J Biol Chem (1983) 1.26
Identification and characterization of an exercise-sensitive pool of glucose transporters in skeletal muscle. J Biol Chem (1995) 1.26
Phosphatidylinositol 4-kinase is a component of glucose transporter (GLUT 4)-containing vesicles. J Biol Chem (1991) 1.26
DNA damage and melanogenesis. Nature (1994) 1.25
UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase. Am J Physiol Endocrinol Metab (2000) 1.24
The major protein of GLUT4-containing vesicles, gp160, has aminopeptidase activity. J Biol Chem (1994) 1.23
Coated vesicles participate in the receptor-mediated endocytosis of insulin. J Cell Biol (1983) 1.23
The insulin receptor. Structural basis for high affinity ligand binding. J Biol Chem (1987) 1.22
Identification and isolation of glycoproteins that translocate to the cell surface from GLUT4-enriched vesicles in an insulin-dependent fashion. J Biol Chem (1994) 1.22
Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge. J Immunol (1988) 1.20
The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol (1981) 1.20
The beta subunit of the insulin receptor is an insulin-activated protein kinase. Biochemistry (1983) 1.20
Structural requirements for the transmembrane activation of the insulin receptor kinase. J Biol Chem (1986) 1.19
p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19
Compartmentalization of protein traffic in insulin-sensitive cells. Am J Physiol (1996) 1.18
Ral and Rab3a are major GTP-binding proteins of axonal rapid transport and synaptic vesicles and do not redistribute following depolarization stimulated synaptosomal exocytosis. Biochim Biophys Acta (1993) 1.18
The formation of an insulin-responsive vesicular cargo compartment is an early event in 3T3-L1 adipocyte differentiation. Mol Biol Cell (1999) 1.18
Decreasing calreticulin expression lowers the Ca2+ response to bradykinin and increases sensitivity to ionomycin in NG-108-15 cells. J Biol Chem (1994) 1.16
The insulin receptor: structure, function, and signaling. Am J Physiol (1994) 1.16
A trans Golgi-derived exocytic coated vesicle can contain both newly synthesized cholinesterase and internalized transferrin. Cell (1987) 1.15
Purification of insulin-dependent exocytic vesicles containing the glucose transporter. J Biol Chem (1987) 1.14
Identification of the glucagon receptor in rat liver membranes by photoaffinity crosslinking. Proc Natl Acad Sci U S A (1981) 1.14
Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol (1984) 1.14
Expression and compartmentalization of caveolin in adipose cells: coordinate regulation with and structural segregation from GLUT4. J Cell Biol (1995) 1.13
Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J Biol Chem (2001) 1.13
Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology (1989) 1.13
Heterogeneity of tubulin. Nat New Biol (1971) 1.12
Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors. J Invest Dermatol (1989) 1.12
Characterization of anti-clathrin serum. FEBS Lett (1978) 1.12
Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-F1 alpha, and histamine in human skin following UVA irradiation. J Invest Dermatol (1983) 1.12
The insulin receptor protein kinase. Physicochemical requirements for activity. J Biol Chem (1983) 1.11
Comparison of glucose-transporter-containing vesicles from rat fat and muscle tissues: evidence for a unique endosomal compartment. Biochem J (1995) 1.11
The metabolic regulation and vesicular transport of GLUT4, the major insulin-responsive glucose transporter. Endocr Rev (1995) 1.11
Apolipoprotein E is synthesized in the retina by Müller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells. J Biol Chem (1996) 1.11
Growth of human keratinocytes on fibronectin -coated plates. Cell Biol Int Rep (1980) 1.10
Dynamics of signaling during insulin-stimulated endocytosis of its receptor in adipocytes. J Biol Chem (1995) 1.08
Immunological analysis of GLUT4-enriched vesicles. Identification of novel proteins regulated by insulin and diabetes. J Biol Chem (1993) 1.07
Effect of thyroid status on insulin action in rat adipocytes and skeletal muscle. J Clin Invest (1980) 1.06
Separation of endocytic from exocytic coated vesicles using a novel cholinesterase mediated density shift technique. Cell (1986) 1.06
Protein phosphotyrosine phosphatase purified from the particulate fraction of human placenta dephosphorylates insulin and growth-factor receptors. Biochem J (1988) 1.06